Baclofen in the treatment of Autism
Not Applicable
Recruiting
- Conditions
- Childhood autism.Childhood autism
- Registration Number
- IRCT201701131556N95
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1-DSM 5 clinical diagnosis of autistic disorder; 2-children between the ages of 3 and 11 years; 3- presence of behavioral problems such as aggression, overactivity or repetitive behaviors (indication of treatment with risperidone).
Exclusion criteria: 1- presence of any active medical problem; 2-any other psychiatric diagnosis except for Intellectual disability; 3-history of allergy to Baclofen; 4- receiving any psychotropic medications during past two weeks prior to the trial; 5-presence of hepatic disease; 6-history of seizure.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of Autism. Timepoint: Baseline and weerks 5 and 10. Method of measurement: Aberrant Behavior Checklist-Community (ABC-C) Rating Scale (irritibility subscale) and Childhood autism rating scale(CARS).
- Secondary Outcome Measures
Name Time Method